0001567619-20-021619.txt : 20201228 0001567619-20-021619.hdr.sgml : 20201228 20201228195202 ACCESSION NUMBER: 0001567619-20-021619 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201223 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCarthy Sean A. CENTRAL INDEX KEY: 0001654058 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 201419784 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD. STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273521219 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2020-12-23 0 0001501989 CytomX Therapeutics, Inc. CTMX 0001654058 McCarthy Sean A. C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2020-12-23 4 M 0 100000 1.1339 A 206894 D Stock Option (Right to Buy) 1.1339 2020-12-23 4 M 0 100000 0.00 D 2021-09-20 Common Stock 100000 192143 D 100% of the shares subject to the option are fully vested and exercisable. /s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy 2020-12-28